ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.557,27
-0,48%
S&P 500
5.346,99
-0,11%
Dow Jones
38.798,99
-0,22%
Euro vs US Dollar
1,0804
-0,12%
Bitcoin
69.456,46
0,18%
Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Kosan Biosciences (MM) (KOSN)

  7. Kosan Biosciences (MM) (KOSN) News

KOSN

Kosan Biosciences (MM) (KOSN)

Kosan Biosciences (MM)
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:KOSN
DatumZeitQuelleÜberschriftSymbolFirma
26/06/200823h39Business WireBristol-Myers Squibb Completes Acquisition of Kosan Biosciences IncorporatedNASDAQ:KOSNKosan Biosciences (MM)
26/06/200822h34Edgar (US Regulatory)Kosan Biosciences Inc - Termination of Registration of a Class of Security under Section 12(g) (15-12G)NASDAQ:KOSNKosan Biosciences (MM)
26/06/200822h20Edgar (US Regulatory)Kosan Biosciences Inc- (25-NSE)NASDAQ:KOSNKosan Biosciences (MM)
26/06/200819h36Edgar (US Regulatory)Kosan Biosciences Inc - Amended Statement of Ownership: Solicitation (SC 14D9/A)NASDAQ:KOSNKosan Biosciences (MM)
26/06/200816h08Edgar (US Regulatory)Kosan Biosciences Inc - Amended tender offer statement by Third Party (SC TO-T/A)NASDAQ:KOSNKosan Biosciences (MM)
19/06/200822h40Edgar (US Regulatory)Kosan Biosciences Inc - Amended Statement of Ownership: Solicitation (SC 14D9/A)NASDAQ:KOSNKosan Biosciences (MM)
19/06/200815h48Edgar (US Regulatory)Kosan Biosciences Inc - Amended tender offer statement by Third Party (SC TO-T/A)NASDAQ:KOSNKosan Biosciences (MM)
03/06/200816h00PR Newswire (US)Kosan's Lead Hsp90 Inhibitor, Tanespimycin, Shows High Level of Activity in Trastuzumab Resistant/Refractory HER2-Positive BreasNASDAQ:KOSNKosan Biosciences (MM)
30/05/200815h33MarketwiredWall Street News Alert: Stocks on the Move for Friday: CPYE! May 30, 2008NASDAQ:KOSNKosan Biosciences (MM)
30/05/200813h15MarketwiredEquity Spotlight for Friday, May 30, 2008: MDII Additional Product Order!NASDAQ:KOSNKosan Biosciences (MM)
29/05/200822h36Edgar (US Regulatory)Kosan Biosciences Inc - Statement of Ownership: Solicitation (SC 14D9)NASDAQ:KOSNKosan Biosciences (MM)
29/05/200822h23Edgar (US Regulatory)Kosan Biosciences Inc - Written communication by the subject company relating to a third party tender offer (SC14D9C)NASDAQ:KOSNKosan Biosciences (MM)
29/05/200820h20Business WireBristol-Myers Squibb Begins Tender Offer to Acquire Kosan Biosciences Inc.NASDAQ:KOSNKosan Biosciences (MM)
29/05/200819h30Edgar (US Regulatory)Kosan Biosciences Inc - Tender offer statement by Third Party (SC TO-T)NASDAQ:KOSNKosan Biosciences (MM)
29/05/200818h32Edgar (US Regulatory)Kosan Biosciences Inc - Current report filing (8-K)NASDAQ:KOSNKosan Biosciences (MM)
29/05/200817h06MarketwiredBellwetherReport.com Analyst Report on KOSN, ACEL, SHLD and SSCCNASDAQ:KOSNKosan Biosciences (MM)
29/05/200815h00Edgar (US Regulatory)Kosan Biosciences Inc - Written communication by the subject company relating to a third party tender offer (SC14D9C)NASDAQ:KOSNKosan Biosciences (MM)
29/05/200814h22Business WireBristol-Myers Squibb to Acquire Kosan BiosciencesNASDAQ:KOSNKosan Biosciences (MM)
29/05/200813h39Business WireBristol-Myers Squibb to Acquire Kosan BiosciencesNASDAQ:KOSNKosan Biosciences (MM)
28/05/200819h27Edgar (US Regulatory)Kosan Biosciences Inc - Statement of Changes in Beneficial Ownership (4)NASDAQ:KOSNKosan Biosciences (MM)
28/05/200819h27Edgar (US Regulatory)Kosan Biosciences Inc - Statement of Changes in Beneficial Ownership (4)NASDAQ:KOSNKosan Biosciences (MM)
28/05/200819h26Edgar (US Regulatory)Kosan Biosciences Inc - Statement of Changes in Beneficial Ownership (4)NASDAQ:KOSNKosan Biosciences (MM)
28/05/200819h25Edgar (US Regulatory)Kosan Biosciences Inc - Statement of Changes in Beneficial Ownership (4)NASDAQ:KOSNKosan Biosciences (MM)
28/05/200819h24Edgar (US Regulatory)Kosan Biosciences Inc - Statement of Changes in Beneficial Ownership (4)NASDAQ:KOSNKosan Biosciences (MM)
28/05/200819h22Edgar (US Regulatory)Kosan Biosciences Inc - Statement of Changes in Beneficial Ownership (4)NASDAQ:KOSNKosan Biosciences (MM)
20/05/200812h00PR Newswire (US)Kosan Appoints Pamela S. Cohen, M.D., as Chief Medical OfficerNASDAQ:KOSNKosan Biosciences (MM)
14/05/200812h00PR Newswire (US)Kosan Announces Data Presentations at ASCO 2008 Annual MeetingNASDAQ:KOSNKosan Biosciences (MM)
12/05/200822h52Edgar (US Regulatory)Kosan Biosciences Inc - Quarterly Report (10-Q)NASDAQ:KOSNKosan Biosciences (MM)
08/05/200821h07Edgar (US Regulatory)Kosan Biosciences Inc - Statement of Changes in Beneficial Ownership (4)NASDAQ:KOSNKosan Biosciences (MM)
08/05/200821h07Edgar (US Regulatory)Kosan Biosciences Inc - Statement of Changes in Beneficial Ownership (4)NASDAQ:KOSNKosan Biosciences (MM)
 Showing the most relevant articles for your search:NASDAQ:KOSN

Kürzlich von Ihnen besucht

NYSE
MRK
Merck
NASDAQ
GOOGL
Alphabet
NASDAQ
NVDA
NVIDIA
TG
LHA
Deutsche Lufthansa
NASDAQ
AMZN
Amazon.com
COIN
ETHUSD
Ethereum
NYSE
XOM
Exxon Mobil
TG
DTE
Deutsche Telekom
TG
BAS
BASF
NYSE
NKE
Nike
DBI
MDAX
MDAX
NASDAQ
QQQ
Invesco QQQ Trust Series 1
DBI
SDXP
SDAX
NASDAQ
MSFT
Microsoft
TG
MBG
MercedesBenz
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten